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Abstract 
Previous studies have suggested that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) undergoes covalent modification of an active site thiol 
by a NV-induced rg2P]NAD’-dependent mechanism. However, the efficacy of GAPDH modification induced by various NO donors was found to 
be independent of spontaneous rates of NO’ release. To further test the validity of this mechanism, we studied the effects of nitrosonium tertrafluorob- 
orate (BF.,NO), a strong NO+ donor. BF,NO potently induces GAPDH labeling by the radioactive nucleotide. In this case, the addition of thiol 
significantly attenuates enzyme modification by competing for the NO moiety in the formation of RSNO. Peroxynitrite (ONOO-) also induces 
GAPDH modification in the presence of thiol, consistent with the notion that this species can transfer NO+ (or NO;) through the intermediacy of 
RS-NO. However, the efficiency of this reaction is limited by ONOO--induced oxidation of protein SH groups at the active site. ONOO- generation 
appears to account for the modification of GAPDH by SIN-l. Thus, S-nitrosylation of the active site thiol is a prequisite for subsequent post- 
translational modification with NAD’, and emphasizes the role of NO’ transfer in the initial step of this pathway. Our findings thus provide a uniform 
mechanism by which nitric oxide and related NO donors initiate non-enzymatic ADP-ribosylation (like) reactions. In biological systems, endogenous 
RS-NO are likely to support the NO group transfer to thiol-containing proteins. 
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1. Introduction 
Nitric oxide (NO’) has gained wide attention because 
of its role in diverse biological processes (see [1,2] for 
references). The molecule is synthesized by a family of 
enzymes termed NO’ synthases (NOS) which utilize 
arginine as their substrate in the 5-electron oxidation of 
the guanidino nitrogen to NO. However, once produced 
by the actions of NOS, NO’ is extremely susceptible to 
both oxidation and reduction, resulting in the formation 
of surrogates that retain NO-like bioactivity [3]. Hence, 
the species accountable for the biological response is 
often ambiguous. This point is well exemplified in the 
case of S-nitrosothiols (RS-NO) which are found in 
many biological systems, and among their diverse func- 
tion serve as bioactive reservoirs of NO that target reac- 
tive sulfhydryl centers [4]. In fact, such heterolytic path- 
ways of RS-NO decomposition (i.. NO’ transfer) may 
predominate in many biological systems and account for 
activity. S-Nitrosothiol-thiol exchange reactions are rep- 
resentative of such heterolytic mechanisms of RS-NO 
decomposition and have been invoked in the allosteric 
modulation of NMDA receptors to limit neurotoxicity 
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Abbreviations: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; 
SNP, sodium nitroprusside; SIN-l, 3-morpholinosydnonimine; DTT, 
dithiothreitol; NAD’, nicotinamide adenine dinucleotide. 
[5], the antimicrobial effects of RS-NO [6], the inhibition 
of sulfhydryl containing enzymes [7,8] and the mecha- 
nism of activiation of stable protein RS-NO in vivo [3]. 
The signal transduction pathways of NO’ can be 
broadly classified as either cyclic GMP-dependent or 
-independent: he former pathway is reasonably well elu- 
cidated and mediates the actions of NO’ in smooth mus- 
cle and platelets (see [1,2] for references). Conforma- 
tional changes induced by NO binding at the heme active 
site of soluble guanylyl cyclase lead to enzymatic conver- 
sion of guanosine triphosphate to guanosine cyclic 3’,5’- 
monophosphate. The cyclic GMP-independent mecha- 
nisms, however, are less well understood. In this regard, 
S-nitrosylation of proteins [9], and ADP-ribosylation 
(like) reactions [lo] have received significant attention. 
S-Nitrosylated peptides and proteins have been identi- 
fied in the salivary gland of rhodnius prolixus [l 11, 
human plasma [3], airway lining fluid [12] and neutro- 
phils [13]. Studies on the mechanism of ADP-ribosyla- 
tion have centered on the covalent NAD’-dependent 
modification of the glycolytic enzyme [14], glyceralde- 
hyde-3-phosphate dehydrogenase (GAPDH), a likely 
function of its intracellular prevalence [15]. This NO- 
dependent reaction has been observed in a variety of 
different cellular systems on activation of NOS, or in- 
duced by the exogenous administration of NO-releasing 
compounds. Nevertheless, saturated gas NO solutions 
show weak activity, even in the presence of oxygen and 
transition metals (see [15] for references). Extending 
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these observations, we observed that the efficacy of var- 
ious NO donors at inducing GAPDH modification 
seemed independent of rates of NO’ release (Table 1). 
The present study was therefore undertaken to better 
characterize the mechanism by which NO’ and related 
NO donors initiate ADP-ribosylation (like) reactions at 
sulfur-containing enzyme centers. 
2. Materials and methods 
2.1. Materials 
t3’P]NAD+ (800 Wmmol) was purchased from Du Pont-New Eng- 
land Nuclear. SIN-l was urovided bv Cassella AG. Frankfurt. Ger- 
many. BF,NO was boughifrom Aldhch, while BF,NO, was obtained 
from Fluka. Rabbit muscle GAPDH (80 U/mg) was ordered from 
Boehringer-Mannheim. Diethylamine NO and spermine NO were ob- 
tained from NC1 Chemical Carcinogen Reference Standard Reposito- 
ries, Kansas City, USA. All other chemicals were purchased from 
Sigma at the highest grade of purity available. 
2.2. Peroxynitrite synthesis 
Peroxynitrite was synthesised as described previously [171. Briefly, an 
ice-cold solution of 0.6 M HCl, 0.7 M H707 (10 ml) was added simulta- 
neously to a well stirred, cooled (4°C) soiution of 0.6 M NaNO, (10 ml), 
followed immediatelv bv addition of 1.5 M NaOH (20 ml). Excess H,O, _ I _  _ 
was removed by addition of MnO,. The mixture was shaken for 30 min 
at 4°C and then filtered (3 times; in order to remove MnO,). This 
solution was frozen at -20°C for up to 1 week. Peroxynitrite forms a 
yellow top layer due to freeze fractionation, which was retained for 
further studies. The top layer typically contained 50-l 50 mM peroxyni- 
trite as determined by W-absorbance spectroscopy at 302 nm in 1 N 
NaGH (& “,,, = 1670 M-’ cm-‘) [I 71. 
2.3. Covalent mod$cation of GAPDH 
GAPDH modifications were generally carried out as previously de- 
scribed (see [ 151 for references). GAPDH (10 &assay) was incubated 
in 100 mM HEPES buffer @H 7.5), 0.15 ,Ki [“PINAD+, l-10 PM 
unlabeled NAD’ in the absence or presence of 2.5 mM D’IT, and a NO 
donor, respectively. After 30 min at 37°C proteins were precipitated 
with 20% trichloroacetic acid followed bv centrifugation (15 min at 
13,000 x g, 4°C). The resulting pellets were washed twice‘with cold 
water-saturated ether and resolved in a 10% SDS-polyacrylamide gel. 
Radioactivity was quantified using the phosphor imager system (Mo- 
lecular Dynamics). 
2.4. Mod$cation of GAPDH with nitrosonium-tetrajuoroborate and 
peroxynitrite 
Stock solutions of BF,NO and BF4N02 were prepared under acidic 
conditions (pH 2; 0.2 M HCl), which promote stability of NO’/NO,‘. 
l-2 ~1 were transferred to our complete GAPDH labeling assay, while 
carefully excluding any pH changes. Peroxynitrite (ONOO-) was rap- 
idly diluted into HEPES buffer maintaining an alkaline pH. For 
GAPDH modification, l-10 ,LL~ were then transferred to our complete 
labeling assay (PH 7.4). BF,NO and peroxynitrite solutions were pre- 
pared fresh every day, just prior to experiments. 
2.5. Pre-incubation experiments using peroxynitrite 
GAPDH was pre-incubated with different concentrations of per- 
oxynitrite in the presence or absence of 2.5 mM DTT for 1 min at 37”C, 
followed by the addion of 200 PM SIN-l. Incubations were performed 
for an additional 30 min, essentially as described in Fig. 1. 
3. Results and discussion 
Previous studies have shown that the active site thiol 
of GAPDH is subject to NO-dependent modification by 
NAD’. We further probed the chemical mechanism of 
the post-translational modification with the use of sev- 
eral NO donors. Sodium nitroprusside (SNP) was found 
to induce incorporation of radiolabeled nucleotide in the 
absence of added reducing equivalents. SNP contains an 
NO group with strong NO’ character, and under certain 
conditions does not liberate NO’ spontaneously [18]. 
These observations uggest hat the NO’ moiety is trans- 
ferred to the critical thiol of GAPDH in the process of 
covalent modification. The addition of DTT was found 
to enhance SNP-induced labeling of the enzyme (Fig. 1). 
Various interpretations of this finding are compatible 
with a mechanism involving S-nitrosylation of active site 
thiol. First, DTT engenders a reducing environment hat 
is a prequisite for any modification of the enzyme active 
site. Second, the reaction of SNP and thiol (i.e. DTT) is 
reported to yield RS-NO which has been shown to in- 
duce modification of GAPDH [14]. In this regard, the 
greater efficacy of RS-NO over SNP may be explained 
by steric constraints at the enzyme active site which limit 
access of the pentacyanoferrate moiety of SNP. Thiol has 
also been reported to facilitate the liberation of NO 
from SNP, although this may occur, at least in part, by 
way of the intermediates of RS-NO (see [18] for refer- 
ences) 
In order to better characterize the redox species in- 
volved in the mechanism of GAPDH modification, stud- 
ies with the NO’ donor nitrosonium tetrafluoroborate 
(BF,NO) were performed. This compound was found to 
be a potent inducer of GAPDH modification. Addition 
of 1 or 2 ~1 of freshly prepared BF,NO stock solutions 
to our GAPDH labeling assay system in the presence of 
[32P]NAD+ produces significant enzyme modification, at 
the relatively low concentrations of 50 ,uM. In contrast 
to SNP, however, the addition of DTT significantly at- 
tenuates GAPDH modification. Thus, the competing 
S-nitrosation reaction with DTT, present in high excess 
over enzyme, predictably hinders the reaction with the 
active site thiol. These data implicate NO’ as the species 
transferred to the active site thiol in the mechanism 
of covalent modification of the enzyme. Our findings are 
in keeping with previous indirect evidence that protein 
Table 1 
Correlation between NO’ generation and GAPDH modification 
Rates of NO GAPDH modification 
release (tl,,)* by NAD’ 
Diethylamine NO 2.2 min 
Spermine NO - 40 min 
S-NO-glutathione 7.8 hr 
Sodium nitroprusside ND 
SIN-l ND** 
+ 
+ 
++ 
++ 
+++ 
GAPDH modification was assayed under standard conditions. 
*Assayed by NO electrode (WPI electrode) and/or oxidation of 
oxymyoglobin to metmyoglobin [16]. 11,~ based on the assumption of 
first order kinetics. 
**Variable results, but generally undetectable or very little release of 
NO. ND, not detectable. 
S. Mohr al. IFEBS Letters 348 (1994) 223-227 225 
control BFflO 
DTT (2SmM) - + - + - + 
SNP (200 pM) + + - - - - 
BF4NO (I-W - - 50 50 75 75 
Fig. 1. Modification of GAPDH by nitrosonium tetrafluoroborate. Covalent GAPDH modification in the presence of [32P]NAD+ was carried out 
as described in section 2. Incubations were performed for 30 rein with DTT, sodium nitroprusside (SNP), and BF,NO. The figure is representative 
of four similar experiments. 
S-nitrosylation preceeds [ 193, and thereby, initiates 
subsequent covalent NAD’-dependent protein modifi- 
cation. 
Studies with the NO donor SIN-l have led to contlict- 
ing reports on the mechanism of GAPDH modification. 
This compound generates nitric oxide and superoxide 
stoichiometrically, at the same time. The diffusion-lim- 
ited radical-radical interaction between these species 
leads to the formation of peroxynitrite (ONOO-) [20]. In 
our studies, the addition of superoxide dismutase was 
found to inhibit SIN-l-induced labeling of the enzyme. 
Direct measurements of NO’ (WPI microelectrode) dem- 
onstrated that superoxide dismutase nhances NO’ pro- 
duction from SIN-l under these conditions. Taken 
together, these data support the conclusion that per- 
oxynitrite mediates the action of SIN-l. In order to rec- 
oncile these findings with a mechanism involving S-ni- 
trosylation, we examined the effects of peroxynitrite in 
greater detail. 
As illustrated in Fig. 2, peroxynitrite causes radioac- 
tive labeling of GAPDH, confirming previous reports 
[lo]. However, the activity of ONOO- was found to be 
critically dependent on the presence of thiol, whereas 
addition of SOD had no effect. Peroxynitrite (SCrlOO 
PM) did not produce substantial protein modification 
unless DTT was included in the reaction mixtures. Under 
control 
these conditions ONOO- was more potent than SNP. 
These findings can be well rationalized by the known 
reactions of peroxynitrite with thiol groups. When pres- 
ent in relative excess, peroxynitrite oxidizes thiols to 
sulfenic or sulfonic acids [21,22], thereby inhibiting sub- 
sequent covalent modification by NAD’. This notion is 
supported by the finding that pretreatment of GAPDH 
with peroxynitrite attenuates the incorporation of radio- 
activity on subsequent stimulation with SIN-l (Fig. 3). 
Indeed, peroxynitrite-induced oxidative inactivation 
of other thiol-containing enzymes, such as succinate de- 
hydrogenase, has recently been reported [23]. In con- 
trast, when thiol is present in relative excess over per- 
oxynitrite, conditions are conducive to the formation of 
RSNO [8,24]. The sequence of events most likely in- 
volves S-nitrosation of DTT by ONOO- followed by 
NO’ donation to the reactive protein SH group. The 
finding that superoxide generating systems (i.e. xanthinel 
xanthine oxidase) do not enhance SNP-induced covalent 
modification of GAPDH in systems replete in thiol (i.e. 
capable of generating NO’) (n = 3) is in keeping with our 
findings that peroxynitrite does not play a direct role in 
this pathway. Moreover, these same studies support the 
previous conclusion that nitric oxide itself is not directly 
involved, as superoxide enhances nitric oxide release 
from SNP [25]. 
ON00 
DTT (2.5 mM) + - + - + - + - + 
SNP (200pM) - + + - - - - - - 
ONOO- (PM) - - - 50 50 75 75 loo loo 
Fig. 2. Modification of GAPDH by peroxynitrite. GAPDH was incubated with DTT, sodium nitroprusside (SNP), and peroxynitrite. Other details 
are as described in Fig. 1 and section 2. Results are representative of eight similar assays. 
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control ONOO’/DTT: preincubation for lmin 
DTT (2.5 mM) _ +-+-+-+-+-+-+ 
SIN-l(200I~M) - -++-------- -- 
ONOO’ (PM) - - - _ 50 50 7s 75 loo loo 150 150 200 200 
SIN-1 (200 j.tM) ++++++++++ 
Fig. 3. Peroxynitrite modulates SIN-l induced covalent GAPDH modification. GAPDH was incubated with DTT, SIN-l and peroxynitrite as 
indicated. The preincubation of DTT/ONOO-, followed by addition of SIN-1 was carried out as described in section 2. Other details are as in 
Fig. 1. Data are representative of three similar experiments. 
Heterolytic mechanisms of ONOO- cleavage in physi- 
ological systems may result in nitration (i.e. reaction of 
transfer of NOz+) of nucleophilic centers [26,27]. As the 
intermediates of thionitrates (RS-NOJ had not been ex- 
cluded in studies in which peroxynitrite induced covalent 
modification of GAPDH, this possibility was further ex- 
plored. Nitronium tetrafluoroborate (BF,N03, a strong 
NO*+ donor, was found to be very effective at inducing 
covalent modification with NAD’ in the absence of 
DTT. This activity was comparable to BF,NO and was 
likewise inhibited by thiol. The physiological importance 
of this observation notwithstanding, S-nitration of the 
enzyme thus supports subsequent covalent modification 
with NAD’. This has important mechanistic implica- 
tions, as it indicates that chemistry shared by NO’ and 
NO*+ initiates subsequent covalent modification with 
NAD’. 
Our findings provide a uniform mechanism by which 
nitric oxide and related NO donors initiate non-enzy- 
matic ADP-ribosylation (like) reactions. S-Nitrosylation 
of the acitive site thiol is a prequisite for subsequent 
modification with NAD’, and emphasizes the role of NO 
group transfer chemistry in the initial step of this mech- 
anism. In biological systems, RS-NO most likely sup- 
port the transfer of the NO moiety to reactive sulfhydryl 
centers of proteins. 
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